Overview

Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-08-14
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of SJP-0132 in Chinese Patients with Dry Eye. Patients will be randomly assigned to receive either SJP-0132 or placebo.
Phase:
PHASE3
Details
Lead Sponsor:
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.
Collaborator:
Senju Pharmaceutical Co., Ltd.